CDIX
Cardiff Lexington Corp
-0.00 (-0.02%)0.65USD2.0K成交股數10.2M市值–本益比(近四季)1.0股價營收比-22.6%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 2.2M-23% | 2.2M-24% | 2.8M+104% | 3.1M+108% | 2.8M+20% | 2.9M+23% | 1.4M-60% | 1.5M-56% | 2.3M | 2.4M | 3.4M | 3.4M |
| 營業成本 | 977K | 904K | 1.0M | 1.1M | 1.1M | 1.1M | 1.0M | 793K | 948K | 971K | 551K | 1.1M |
| 毛利 | 1.2M-30% | 1.3M-28% | 1.8M+396% | 1.9M+181% | 1.7M+23% | 1.8M+31% | 355K-88% | 679K-70% | 1.4M | 1.4M | 2.9M | 2.3M |
| 毛利率 | 54.7% | 59.3% | 63.5% | 62.4% | 60.8% | 63.1% | 26.2% | 46.1% | 59.2% | 59.1% | 83.8% | 67.8% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 1.4M | 1.2M | 1.8M | 1.2M | 987K | 1.3M | 937K | 835K | 851K | 981K | 578K | 530K |
| 營業利益 | −545K-189% | −511K-194% | −696K+19% | 643K-503% | 610K+178% | 544K+31% | −585K-126% | −159K-109% | 219K | 415K | 2.3M | 1.7M |
| 營業利益率 | -25.2% | -23.0% | -25.1% | 21.0% | 21.9% | 18.7% | -43.2% | -10.8% | 9.4% | 17.4% | 66.7% | 52.0% |
| 稅後淨利 | −2.5M+102% | −3.1M+586% | −2.7M+36% | −1.1M+770% | −1.2M+333% | −451K-283% | −2.0M-200% | −132K-116% | −283K | 247K | 2.0M | 816K |
| 淨利率 | -114.8% | -139.1% | -96.9% | -37.4% | -44.0% | -15.5% | -145.9% | -8.9% | -12.2% | 10.4% | 58.2% | 24.3% |
| 稀釋 EPS | -0.18-25% | -0.23+64% | – | – | -0.24 | -0.14 | – | – | – | – | – | – |
| 稀釋股數 | 15.3M | 14.5M | 8.5M | 19.8M | 6.2M | 5.1M | 14.1M | 12.8M | 3.8M | 15.0K | 795K | 192K |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 218K | 684K | 319K | 232K | 560K | 997K | 1.9M | 3.2M | 1.3M | 867K | 181K | 408K |
| 應收帳款 | 23.7M | 22.9M | 22.1M | 20.7M | 19.2M | 17.5M | 14.8M | 14.9M | 14.6M | 13.3M | 11.8M | 9.2M |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 30.7M | 30.3M | 29.1M | 27.6M | 26.5M | 25.3M | 23.5M | 24.7M | 22.6M | 20.7M | 18.5M | 16.1M |
| 有息負債 | 22.7M | – | 18.6M | 15.1M | 13.1M | 10.7M | 8.2M | 7.4M | 3.7M | 2.3M | 169K | 169K |
| 總負債 | 27.1M | 24.6M | 26.0M | 22.6M | 20.5M | 18.2M | 15.0M | 14.2M | 15.4M | 14.1M | 12.1M | 11.7M |
| 股東權益 | 1.8M | 3.9M | −2.5M | −364K | 754K | 2.0M | 3.7M | 5.9M | 1.2M | 731K | 676K | −1.1M |
| 負債比 | 88.3% | 81.3% | 89.4% | 81.8% | 77.5% | 72.0% | 63.9% | 57.5% | 67.9% | 68.1% | 65.4% | 72.7% |
| 淨現金(現金 − 有息負債) | −22.5M | – | −18.2M | −14.8M | −12.5M | −9.7M | −6.3M | −4.2M | −2.5M | −1.4M | 12K | 239K |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −17K-97% | – | – | – | −491K | – | – | −1.0M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | 593.00 | – | – | 763.00 | 3K | 3K | 3K | 3K | 9K | 3K | 3K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | 0 | – | – | – | 50K | – | – | 0 | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 11.5M
| Healthcare | 11.5M | 100.0% | +39.5% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 11.5M | +39.5% | −5.5M | -47.7% | – | – |
| FY2024 | 8.3M | -30.2% | −3.3M | -39.9% | – | – |
| FY2023 | 11.9M | +10.8% | 3.0M | 25.5% | – | – |
| FY2022 | 10.7M | +8.2% | −5.4M | -50.8% | – | −1.2M |
| FY2021 | 9.9M | +186.1% | 666K | 6.7% | -0.01 | −854K |
| FY2020 | 3.5M | -24.0% | −2.8M | -82.2% | – | −903K |
| FY2019 | 4.5M | +103.9% | −7.2M | -158.1% | – | – |
| FY2018 | 2.2M | – | −6.3M | -281.3% | -0.01 | −2.0M |